Engineered PanB Microorganisms for D-Form Pantothenic Acid Production

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing pantothenic acid and pantoic acid are inefficient and require improvements to enhance production efficiency and stereoisomeric specificity.

Innovation Solution

A recombinant strain with enhanced 3-methyl-2-oxobutanoate hydroxymethyltransferase activity is introduced into microorganisms such as Corynebacterium and Escherichia, through targeted amino acid substitutions at specific positions in the enzyme's sequence, increasing the production of pantothenic acid and pantoic acid.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If chemical synthesis is used to prepare pantothenic acid, then production efficiency can be improved, but stereoisomeric specificity deteriorates (cannot produce desired D-form)

Engineering Contradiction:
Improveproduction efficiencyVSAvoidstereoisomeric specificity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The invention changes the biological parameters of the microorganism by introducing mutated panB genes with specific amino acid substitutions (Gly116, Ala159, Thr160, Ala205 positions) to enhance enzyme activity and stereospecificity while maintaining high production efficiency through optimized fermentation conditions

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention uses biotechnological copying of the desired D-form stereochemistry through genetically modified microorganisms that naturally produce the correct stereoisomer, avoiding the need for chemical synthesis while achieving both efficiency and specificity

Inventive Principle:
Principle #26Copying

2Manufacturing precision

If existing biotechnological methods are used to prepare pantothenic acid, then stereoisomeric specificity is improved (D-form production), but productivity deteriorates (low production efficiency)

Engineering Contradiction:
Improvestereoisomeric specificityVSAvoidproduction efficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The invention changes the enzymatic parameters by introducing specific amino acid mutations in the panB gene (particularly at positions 116, 159, 160, and 205) to significantly enhance 3-methyl-2-oxobutanoate hydroxymethyltransferase activity, thereby increasing production efficiency while preserving stereospecificity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention replaces the natural, low-efficiency enzymatic system with an engineered hyper-active enzyme system through genetic modification, substituting the natural biological mechanism with an enhanced version that maintains stereochemical fidelity while dramatically improving productivity

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Productivity

If amino acid substitutions are introduced to enhance enzyme activity, then productivity is improved, but device complexity deteriorates (genetic modification complexity)

Engineering Contradiction:
Improveproduction capabilityVSAvoidgenetic modification complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The invention applies local quality changes by introducing targeted amino acid substitutions at specific positions (Gly116, Ala159, Thr160, Ala205) in the panB enzyme rather than global modifications, achieving enhanced productivity through localized, precise genetic changes that minimize overall system complexity

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The modified microorganisms exhibit significantly improved production capabilities of pantothenic acid and pantoic acid, surpassing the efficiency of previous methods.

Implementation Method 1

3-methyl-2-oxobutanoate hydroxymethyltransferase activity

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentEP4112726B1Microorganism having enhanced activity of 3-methyl-2-oxobutanoate hydroxymethyltransferase and uses thereof
Publication Date: 2025.09.24 CJ CHEILJEDANG CORP
  • EP4112726B1 patent drawing
  • EP4112726B1 patent drawing

AI summary

A 3-methyl-2-oxobutanoate hydroxymethyltransferase variant, a microorganism having enhanced activity of 3-methyl-2-oxobutanoate hydroxymethyltransferase, a composition for producing pantothenic acid and/or pantoic acid comprising the microorganism, and a method for preparing pantothenic acid and/or pantoic acid comprising culturing the microorganism are provided.